Reneo Pharmaceuticals: Q4 Earnings Insights
Reneo Pharmaceuticals: Q4 Earnings Insights
Reneo Pharmaceuticals (NASDAQ:RPHM) reported its Q4 earnings results on Thursday, March 28, 2024 at 07:35 AM.
Reneo Pharmicals（納斯達克股票代碼：RPHM）於2024年3月28日星期四上午7點35分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Reneo Pharmaceuticals missed estimated earnings by -13.0%, reporting an EPS of $-0.7 versus an estimate of $-0.62.
Reneo Pharmicals報告的每股收益爲-0.7美元，未達到預期的-13.0％，而預期的收益爲-0.62美元。
Revenue was down $0 from the same period last year.
收入比去年同期下降了0美元。
Past Earnings Performance
過去的收益表現
Last quarter the company missed on EPS by $0.0 which was followed by a 1.0% increase in the share price the next day.
上個季度，該公司的每股收益未達到0.0美元，隨後第二天股價上漲了1.0％。
** Listen to the earnings announcement yourself by clicking here. **
** 點擊此處親自收聽業績公告。**
To track all earnings releases for Reneo Pharmaceuticals visit their earnings calendar here.
要追蹤Reneo製藥公司發佈的所有業績，請在此處訪問其業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。